[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Cell-Free Fetal DNA Testing-United States Market Status and Trend Report 2013-2023

March 2018 | 153 pages | ID: C4E7EAD437DMEN
MIReports Co., Limited

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Summary

Cell-Free Fetal DNA Testing-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Cell-Free Fetal DNA Testing industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Whole United States and Regional Market Size of Cell-Free Fetal DNA Testing 2013-2017, and development forecast 2018-2023
Main market players of Cell-Free Fetal DNA Testing in United States, with company and product introduction, position in the Cell-Free Fetal DNA Testing market
Market status and development trend of Cell-Free Fetal DNA Testing by types and applications
Cost and profit status of Cell-Free Fetal DNA Testing, and marketing status
Market growth drivers and challenges

The report segments the United States Cell-Free Fetal DNA Testing market as:

United States Cell-Free Fetal DNA Testing Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
New England
The Middle Atlantic
The Midwest
The West
The South
Southwest

United States Cell-Free Fetal DNA Testing Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Abnormal Chromosome Number Detection
Gender Testing
Paternally Inherited Disorder Detection
Paternity testing
Otehrs

United States Cell-Free Fetal DNA Testing Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital
Clinic Center

United States Cell-Free Fetal DNA Testing Market: Players Segment Analysis (Company and Product introduction, Cell-Free Fetal DNA Testing Sales Volume, Revenue, Price and Gross Margin):
Sequenom Laboratories
Illumina, Inc.
Ariosa Diagnostics
Arup Laboratories
The Fetal Medicine Centre
Apollo Path labs

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF CELL-FREE FETAL DNA TESTING

1.1 Definition of Cell-Free Fetal DNA Testing in This Report
1.2 Commercial Types of Cell-Free Fetal DNA Testing
  1.2.1 Abnormal Chromosome Number Detection
  1.2.2 Gender Testing
  1.2.3 Paternally Inherited Disorder Detection
  1.2.4 Paternity testing
  1.2.5 Otehrs
1.3 Downstream Application of Cell-Free Fetal DNA Testing
  1.3.1 Hospital
  1.3.2 Clinic Center
1.4 Development History of Cell-Free Fetal DNA Testing
1.5 Market Status and Trend of Cell-Free Fetal DNA Testing 2013-2023
  1.5.1 United States Cell-Free Fetal DNA Testing Market Status and Trend 2013-2023
  1.5.2 Regional Cell-Free Fetal DNA Testing Market Status and Trend 2013-2023

CHAPTER 2 UNITED STATES MARKET STATUS AND FORECAST BY REGIONS

2.1 Market Status of Cell-Free Fetal DNA Testing in United States 2013-2017
2.2 Consumption Market of Cell-Free Fetal DNA Testing in United States by Regions
  2.2.1 Consumption Volume of Cell-Free Fetal DNA Testing in United States by Regions
  2.2.2 Revenue of Cell-Free Fetal DNA Testing in United States by Regions
2.3 Market Analysis of Cell-Free Fetal DNA Testing in United States by Regions
  2.3.1 Market Analysis of Cell-Free Fetal DNA Testing in New England 2013-2017
  2.3.2 Market Analysis of Cell-Free Fetal DNA Testing in The Middle Atlantic 2013-2017
  2.3.3 Market Analysis of Cell-Free Fetal DNA Testing in The Midwest 2013-2017
  2.3.4 Market Analysis of Cell-Free Fetal DNA Testing in The West 2013-2017
  2.3.5 Market Analysis of Cell-Free Fetal DNA Testing in The South 2013-2017
  2.3.6 Market Analysis of Cell-Free Fetal DNA Testing in Southwest 2013-2017
2.4 Market Development Forecast of Cell-Free Fetal DNA Testing in United States 2018-2023
  2.4.1 Market Development Forecast of Cell-Free Fetal DNA Testing in United States 2018-2023
  2.4.2 Market Development Forecast of Cell-Free Fetal DNA Testing by Regions 2018-2023

CHAPTER 3 UNITED STATES MARKET STATUS AND FORECAST BY TYPES

3.1 Whole United States Market Status by Types
  3.1.1 Consumption Volume of Cell-Free Fetal DNA Testing in United States by Types
  3.1.2 Revenue of Cell-Free Fetal DNA Testing in United States by Types
3.2 United States Market Status by Types in Major Countries
  3.2.1 Market Status by Types in New England
  3.2.2 Market Status by Types in The Middle Atlantic
  3.2.3 Market Status by Types in The Midwest
  3.2.4 Market Status by Types in The West
  3.2.5 Market Status by Types in The South
  3.2.6 Market Status by Types in Southwest
3.3 Market Forecast of Cell-Free Fetal DNA Testing in United States by Types

CHAPTER 4 UNITED STATES MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY

4.1 Demand Volume of Cell-Free Fetal DNA Testing in United States by Downstream Industry
4.2 Demand Volume of Cell-Free Fetal DNA Testing by Downstream Industry in Major Countries
  4.2.1 Demand Volume of Cell-Free Fetal DNA Testing by Downstream Industry in New England
  4.2.2 Demand Volume of Cell-Free Fetal DNA Testing by Downstream Industry in The Middle Atlantic
  4.2.3 Demand Volume of Cell-Free Fetal DNA Testing by Downstream Industry in The Midwest
  4.2.4 Demand Volume of Cell-Free Fetal DNA Testing by Downstream Industry in The West
  4.2.5 Demand Volume of Cell-Free Fetal DNA Testing by Downstream Industry in The South
  4.2.6 Demand Volume of Cell-Free Fetal DNA Testing by Downstream Industry in Southwest
4.3 Market Forecast of Cell-Free Fetal DNA Testing in United States by Downstream Industry

CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF CELL-FREE FETAL DNA TESTING

5.1 United States Economy Situation and Trend Overview
5.2 Cell-Free Fetal DNA Testing Downstream Industry Situation and Trend Overview

CHAPTER 6 CELL-FREE FETAL DNA TESTING MARKET COMPETITION STATUS BY MAJOR PLAYERS IN UNITED STATES

6.1 Sales Volume of Cell-Free Fetal DNA Testing in United States by Major Players
6.2 Revenue of Cell-Free Fetal DNA Testing in United States by Major Players
6.3 Basic Information of Cell-Free Fetal DNA Testing by Major Players
  6.3.1 Headquarters Location and Established Time of Cell-Free Fetal DNA Testing Major Players
  6.3.2 Employees and Revenue Level of Cell-Free Fetal DNA Testing Major Players
6.4 Market Competition News and Trend
  6.4.1 Merger, Consolidation or Acquisition News
  6.4.2 Investment or Disinvestment News
  6.4.3 New Product Development and Launch

CHAPTER 7 CELL-FREE FETAL DNA TESTING MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA

7.1 Sequenom Laboratories
  7.1.1 Company profile
  7.1.2 Representative Cell-Free Fetal DNA Testing Product
  7.1.3 Cell-Free Fetal DNA Testing Sales, Revenue, Price and Gross Margin of Sequenom Laboratories
7.2 Illumina, Inc.
  7.2.1 Company profile
  7.2.2 Representative Cell-Free Fetal DNA Testing Product
  7.2.3 Cell-Free Fetal DNA Testing Sales, Revenue, Price and Gross Margin of Illumina, Inc.
7.3 Ariosa Diagnostics
  7.3.1 Company profile
  7.3.2 Representative Cell-Free Fetal DNA Testing Product
  7.3.3 Cell-Free Fetal DNA Testing Sales, Revenue, Price and Gross Margin of Ariosa Diagnostics
7.4 Arup Laboratories
  7.4.1 Company profile
  7.4.2 Representative Cell-Free Fetal DNA Testing Product
  7.4.3 Cell-Free Fetal DNA Testing Sales, Revenue, Price and Gross Margin of Arup Laboratories
7.5 The Fetal Medicine Centre
  7.5.1 Company profile
  7.5.2 Representative Cell-Free Fetal DNA Testing Product
  7.5.3 Cell-Free Fetal DNA Testing Sales, Revenue, Price and Gross Margin of The Fetal Medicine Centre
7.6 Apollo Path labs
  7.6.1 Company profile
  7.6.2 Representative Cell-Free Fetal DNA Testing Product
  7.6.3 Cell-Free Fetal DNA Testing Sales, Revenue, Price and Gross Margin of Apollo Path labs

CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF CELL-FREE FETAL DNA TESTING

8.1 Industry Chain of Cell-Free Fetal DNA Testing
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis

CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF CELL-FREE FETAL DNA TESTING

9.1 Cost Structure Analysis of Cell-Free Fetal DNA Testing
9.2 Raw Materials Cost Analysis of Cell-Free Fetal DNA Testing
9.3 Labor Cost Analysis of Cell-Free Fetal DNA Testing
9.4 Manufacturing Expenses Analysis of Cell-Free Fetal DNA Testing

CHAPTER 10 MARKETING STATUS ANALYSIS OF CELL-FREE FETAL DNA TESTING

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 REPORT CONCLUSION

CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE

12.1 Methodology/Research Approach
  12.1.1 Research Programs/Design
  12.1.2 Market Size Estimation
  12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
  12.2.1 Secondary Sources
  12.2.2 Primary Sources
12.3 Reference


More Publications